Nanoengineering has emerged as a groundbreaking discipline within the pharmaceutical field, revolutionizing drug delivery and therapeutic interventions. At the intersection of nanotechnology and pharmaceuticals, nanoengineering involves the design, manipulation, and application of materials at the nanoscale to enhance drug efficacy and minimize adverse effects. By exploiting the unique properties exhibited by materials at the nanoscale, such as increased surface area and improved bioavailability, nanoengineering enables precise control over drug release kinetics and targeted delivery to specific cells or tissues.
This approach holds tremendous promise for addressing challenges associated with traditional drug formulations, including poor solubility and systemic toxicity. Nanoengineered pharmaceuticals, often in the form of nanoparticles or liposomes, can traverse biological barriers more effectively, allowing for enhanced therapeutic outcomes. Moreover, the ability to incorporate imaging agents into these nanostructures facilitates real-time monitoring of drug distribution within the body. As nanoengineering continues to evolve, it offers unparalleled opportunities to optimize drug design, improve patient compliance, and usher in a new era of personalized medicine in the pharmaceutical landscape.
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Andreas M Papas
Antares Health Products, United States
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian FederationSubmit your abstract Today
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico
Title : Antibody-proteases as translational tools of the next-step generation to be applied for biopharmacy-related and precision medical practice
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia